WallStreetZenWallStreetZen

NASDAQ: PTIX
Protagenic Therapeutics Inc Stock Ownership - Who owns Protagenic Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protagenic Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alexander K. ArrowChief Financial Officer2023-10-128,000$0.81
$6.48kBuy

1 of 1

PTIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTIX insiders and whales buy or sell their stock.

PTIX Shareholders

What type of owners hold Protagenic Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alexander K. Arrow1.03%45,815$28.82kInsider
Vanguard Group Inc0.74%33,166$20.86kInstitution
Geode Capital Management LLC0.65%29,130$18.32kInstitution
Susquehanna International Group LLP0.60%26,598$16.73kInstitution
Osaic Holdings Inc0.48%21,414$13.47kInstitution
Fny Investment Advisers LLC0.42%18,750$11.79kInstitution
State Street Corp0.31%13,812$8.69kInstitution
Ubs Group Ag0.23%10,078$6.34kInstitution
Tower Research Capital LLC Trc0.15%6,806$4.28kInstitution
Bank Of America Corp0.00%29$18.24Institution

1 of 2

PTIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTIX3.58%1.03%Net Buying
INM3.30%5.07%Net BuyingNet Selling
TNXP1.49%70.58%
PHIO0.16%99.84%Net Buying
ELAB0.75%88.30%
View Top Biotech Stocks

Protagenic Therapeutics Stock Ownership FAQ

Who owns Protagenic Therapeutics?

Protagenic Therapeutics (NASDAQ: PTIX) is owned by 3.58% institutional shareholders, 1.03% Protagenic Therapeutics insiders, and 95.40% retail investors. Alexander K. Arrow is the largest individual Protagenic Therapeutics shareholder, owning 45,815.00 shares representing 1.03% of the company. Alexander K. Arrow's Protagenic Therapeutics shares are currently valued at $29.14k.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.